FDA panel recommends approval for experimental leukemia treatment
Thursday, July 13, 2017 - 09:52
in Health & Medicine
The first treatment to genetically alter a patient's own cells, to fight relapsed B-cell acute lymphoblastic leukemia, is one step closer to FDA approval.